文献速递头颈部肿瘤放疗中枢神经肿瘤放疗

头颈癌放疗患者的疲乏:患者报告结局及其与小脑放疗剂量关联的前瞻性研究

Fatigue in Patients With Head and Neck Cancer Treated With Radiation Therapy: A Prospective Study of Patient-Reported Outcomes and Their Association With Radiation Dose to the Cerebellum.
PubMed 文献 · Adv Radiat Oncol · 2022-04-08

本研究前瞻性纳入2008至2010年间接受调强放疗的126例头颈癌患者,用QLQ-C30和QLQ-FA12问卷在治疗前及治疗后1、3、6、12、24、60个月评估患者报告疲乏。躯体疲乏从基线至3个月升高(29 vs 59;P < .0001),1至5年与基线无差异;小脑Dmean > 3.5 Gy者3个月躯体疲乏评分更高(38 vs 27;P = .036)。

要点

  • 躯体疲乏从基线至3个月升高(29 vs 59;P < .0001),1至5年与基线无差异。
  • 5年时情感疲乏显著低于基线(14 vs 28;P < .0001)。
  • 小脑Dmean > 3.5 Gy者3个月躯体疲乏评分更高(38 vs 27;P = .036)。

核心结论

  • 头颈癌放疗患者疲乏评分在放疗后至1年显著升高,但5年时恢复至基线水平。
  • 发现躯体疲乏与小脑更高平均剂量可能存在关联。

研究设计与样本

  • 前瞻性研究,纳入2008至2010年间接受根治性调强放疗的头颈癌患者,最终126例可分析。
  • 于治疗前及治疗开始后1、3、6、12、24、60个月发放欧洲癌症研究与治疗组织QLQ-C30和QLQ-FA12生活质量问卷评估患者报告疲乏。
  • 评估小脑和脑干的平均剂量(Dmean)及近最大剂量(D2%)与3个月时基线校正后疲乏评分的关联。

主要发现

  • 女性及年龄<60岁与基线疲乏更高相关。
  • 同时接受化疗的患者6个月时躯体和情感疲乏降低。
  • 躯体疲乏(QLQ-FA12量表)从基线至3个月升高(29 vs 59;P < .0001),1至5年与基线无差异。
  • 5年时情感疲乏显著低于基线(14 vs 28;P < .0001)。
  • 小脑Dmean > 3.5 Gy者3个月时平均躯体疲乏评分更高(38 vs 27;P = .036)。

关键数值与推荐

  • 小脑Dmean > 3.5 Gy者3个月平均躯体疲乏评分为38,小脑Dmean ≤ 3.5 Gy者为27(P = .036)。
  • 躯体疲乏评分基线29 vs 3个月59(P < .0001)。
  • 情感疲乏评分基线28 vs 5年14(P < .0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Although fatigue is a known side effect in patients with head and neck cancer (HNC) receiving radiation therapy, knowledge regarding long-term fatigue and dose-response relationships to organs at risk is scarce. The aim of this prospective study was to analyze patient-reported fatigue in patients with HNC receiving radiation therapy and to explore any possible association with organ-at-risk doses. METHODS AND MATERIALS: Patients with HNC referred for curative radiation therapy were eligible for inclusion in the study. To assess patient-reported fatigue, quality of life questionnaires (European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-FA12) were distributed before treatment and 1, 3, 6, 12, 24, and 60 months after the start of treatment. Mean dose (Dmean) and near maximum dose (D2%) of the cerebellum and brain stem were evaluated in relation to baseline-adjusted fatigue scores at 3 months. RESULTS: One hundred twenty-six patients treated with intensity modulated radiation therapy between 2008 and 2010 were available for final analysis. Female sex and age <60 years were associated with higher fatigue at baseline, whereas patients also treated with chemotherapy had reduced physical and emotional fatigue at 6 months. Physical fatigue (QLQ-FA12 scale) increased from baseline up to 3 months (29 vs 59; P < .0001) but showed no difference compared with baseline from 1 to 5 years. Emotional fatigue was significantly lower at 5 years compared with baseline (14 vs 28; P < .0001). Patients with cerebellum Dmean > 3.5 Gy had higher mean physical fatigue scores at 3 months (38 vs 27; P = .036). CONCLUSIONS: Although there is a significant increase in fatigue scores for patients with HNC up to 1 year after radiation therapy, this study showed a return to baseline levels at 5 years. A possible association was found between physical fatigue and a higher mean dose to the cerebellum.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Abel E, Silander E, Nordström F, et al. Fatigue in Patients With Head and Neck Cancer Treated With Radiation Therapy: A Prospective Study of Patient-Reported Outcomes and Their Association With Radiation Dose to the Cerebellum. Adv Radiat Oncol. 2022. PMID: 35847551. doi:10.1016/j.adro.2022.100960

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。